Business Context and Reporting Period
Company: SkinHealth Systems Inc. (SKIN)
Filing Type: Form 8-K (Current Report)
Date of Report: May 8, 2026
Event: Notice of delisting or failure to satisfy a continued listing rule regarding the Minimum Bid Price Requirement on The Nasdaq Capital Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on regulatory compliance status regarding stock price.
Material Changes and Listing Status
- Non-Compliance Trigger: The closing bid price of the Class A Common Stock was less than $1.00 per share for 30 consecutive business days (March 26, 2026, through May 7, 2026).
- Current Status: The stock continues to trade on The Nasdaq Capital Market under the symbol "SKIN" with no immediate effect on trading.
- Compliance Period: The Company has 180 calendar days (until November 4, 2026) to regain compliance.
- Requirement to Cure: The closing bid price must be at least $1.00 per share for a minimum of ten consecutive business days during the compliance period.
Outlook, Risks, and Contingencies
- Additional Compliance Period: If the Company fails to regain compliance by November 4, 2026, it may be eligible for an additional 180-day period. Qualification requires meeting the market value of publicly held shares requirement and other initial listing standards, potentially necessitating a reverse stock split.
- Delisting Risk: Failure to regain compliance within the applicable periods will result in a notice of delisting. The Company may appeal this determination to a Nasdaq Hearings Panel.
- Management Intent: The Company intends to monitor the stock price and consider available options to resolve the deficiency, though there is no assurance of success.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from expectations due to various risks.
Investor Verification Checklist
- Verify the current closing bid price of SKIN stock to assess proximity to the $1.00 threshold.
- Monitor the Company's announcements regarding potential reverse stock splits or other capital structure changes.
- Review the Company's most recent Form 10-K or 10-Q for underlying financial performance issues that may be driving the low stock price.
- Track the 180-day compliance deadline (November 4, 2026) for potential delisting notices.